UNSPSC 51372026: Levomethorphan hydrobromide

This classification denotes an opioid receptor agonist with the molecular formula C18H25NO.BrH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9YNW43KIJI, chemically known as morphinan, 3-methoxy-17-methyl-, hydrobromide (1:1), but more generally known as levomethorphan hydrobromide, which bears US NIH Compound Identifier 5486607. European Medicines Agency schedules levomethorphan hydrobromide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08478MIG.

Most nations, for tariff purposes, schedule levomethorphan hydrobromide under HS 29334990. SMILES: CN1CC[C@]23CCCC[C@H]2[C@H]1CC4C3CC(CC4)OC.BR.

UNSPSC 51372026 Levomethorphan hydrobromide is a Commodity code that in practice covers pharmaceutical products and drug-related procurement by state and local health agencies, though recent solicitations under this code show significant scope mismatch — the three opportunities posted in 2026 involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and OTC products, none of which are levomethorphan hydrobromide specifically. State and local issuing bodies soliciting under this code include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving Minnesota, Oregon, and participating jurisdictions). The code appears to capture pharmaceutical procurement broadly rather than a single active pharmaceutical ingredient, suggesting either tagging inconsistency or a code hierarchy that state and local systems apply to all pharmaceutical line items.

Recent activity spans Florida, Texas, and Minnesota-Oregon. Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: date discrepancy in source), requiring quarterly deliveries to the Seminole County Community Health Building in Sanford with a two-year initial term and one-year renewal option. The Texas HHS Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer prescription program serving self-insured employer and state agency health plans, signaling pre-procurement market research rather than an active bid. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, released RFP S1070000015802 on January 20, 2026, for multi-source generic pharmaceuticals and OTC products, with a response deadline of March 26, 2026, and contract effectiveness targeted for July 1, 2026; this procurement requires vendors to work through three authorized wholesalers and evaluated pricing competitiveness at 75 percent weight.